Get the Stockscreener App
30.58
0.05%
-0.0149
After Hours:
30.58
-0.0021
-0.01%
Putnam Biorevolution Etf stock is traded at $30.58, with a volume of 100.
It is down -0.05% in the last 24 hours and up +1.26% over the past month.
See More
Previous Close:
$30.60
Open:
$30.5821
24h Volume:
100
Relative Volume:
0.42
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.78%
1M Performance:
+1.26%
6M Performance:
-1.12%
1Y Performance:
+3.83%
1-Day Range:
$30.58
$30.58
1-Week Range:
$30.36
$30.76
52-Week Range:
$28.68
$33.23
Putnam Biorevolution Etf Stock (SYNB) Company Profile
Name
Putnam Biorevolution Etf
Sector
Industry
Phone
-
Address
-
Compare SYNB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SYNB
Putnam Biorevolution Etf
|
30.58 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
300.69 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
606.32 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
609.40 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
250.24 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
529.60 | 124.43B | 0 | 0 | 0 | 0.00 |
Putnam Biorevolution Etf Stock (SYNB) Latest News
Alphabet’s earnings slide has weighed on the ETF market - MSN
How To Trade (SYNB) - news.stocktradersdaily.com
Net Asset Value(s) - GlobeNewswire Inc.
(SYNB) Investment Analysis - Stock Traders Daily
Chemical Company DuPont Accelerates Electronics Business Separation, Retains Water Business - Benzinga
(SYNB) Technical Pivots with Risk Controls - Stock Traders Daily
Where are the Opportunities in (SYNB) - Stock Traders Daily
(SYNB) Trading Report - Stock Traders Daily
(SYNB) On The My Stocks Page - Stock Traders Daily
(SYNB) Long Term Investment Analysis - Stock Traders Daily
Objective long/short (SYNB) Report - Stock Traders Daily
5 Best Performing Biotech ETFs in 2024 - Insider Monkey
Ginkgo Bioworks (DNA) Stock Price, News & Analysis - MarketBeat
Putnam Investments Launches Five New ESG-Focused ETFs - ESG News
These long-duration bond ETFs have cratered the most from their peaks over past year, sinking below other assets as U.S. dollar soars - MarketWatch
Putnam Investments to Launch Two Innovative Active ETFs - Business Wire
Putnam to expand suite with its first fully transparent active ETFs - Financial Times
Putnam Biorevolution Etf Stock (SYNB) Financials Data
There is no financial data for Putnam Biorevolution Etf (SYNB). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.14%
0.69%
Cap:
|
Volume (24h):